Email This Article
Biopure Admits Its Blood Substitute Will Be Delayed
By
Adam Feuerstein
12/07/01 - 10:31 AM EST
The biotech won't meet a year-end deadline, saying Hemopure won't go to the FDA before mid-2002.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,269.34 | 1,096.13 | 2,161.37 | 34.74 |
Oil *
77.37
|
|
UP
22.37
|
UP
3.12
|
UP
10.29
|
DOWN
0.08
|
10 Yr
3.47%
SPDR Gold
109.09
|
|
+0.22%
|
+0.29%
|
+0.48%
|
-0.23%
|
Data delayed 20 minutes |


Connect with TheStreet